Bio-Rad Laboratories (BIO)
NYSE:BIO
Holding BIO?
Track your performance easily

Bio-Rad Laboratories (BIO) Financial Statements

844 Followers

Bio-Rad Laboratories Financial Overview

Bio-Rad Laboratories's market cap is currently ―. The company's EPS TTM is $-47.037; its P/E ratio is -7.24; Bio-Rad Laboratories is scheduled to report earnings on October 24, 2024, and the estimated EPS forecast is $1.42. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 638.50M$ 610.82M$ 681.18M$ 632.12M$ 681.11M
Gross Profit$ 355.12M$ 325.97M$ 366.36M$ 335.68M$ 362.48M
EBIT$ -2.77B$ 503.36M$ 440.75M$ 149.50M$ -1.49B
EBITDA$ -2.77B$ 540.46M$ 477.95M$ 149.50M$ -1.49B
Net Income Common Stockholders$ -2.17B$ 383.92M$ 349.71M$ 106.26M$ -1.16B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.62B$ 1.65B$ 1.61B$ 1.76B$ 1.72B
Total Assets$ 9.69B$ 11.83B$ 12.30B$ 11.12B$ 11.98B
Total Debt$ 1.39B$ 1.40B$ 1.41B$ 1.41B$ 1.38B
Net Debt$ -223.41M$ -245.95M$ -201.75M$ -353.51M$ -340.43M
Total Liabilities$ 2.91B$ 3.56B$ 3.56B$ 3.48B$ 3.53B
Stockholders Equity$ 6.78B$ 9.05B$ 8.74B$ 8.42B$ 8.45B
Cash Flow-
Free Cash Flow$ 55.43M$ 29.64M$ 38.80M$ 141.06M$ 63.47M
Operating Cash Flow$ 97.65M$ 69.79M$ 81.05M$ 185.07M$ 98.07M
Investing Cash Flow$ -30.93M$ -43.09M$ 72.20M$ -9.50M$ 27.98M
Financing Cash Flow$ -96.59M$ 21.00K$ -200.62M$ -26.60M$ -202.74M
Currency in USD

Bio-Rad Laboratories Earnings and Revenue History

Bio-Rad Laboratories Debt to Assets

Bio-Rad Laboratories Cash Flow

Bio-Rad Laboratories Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis